The report provides a detailed analysis essential for establishing a Largazole production plant. It encompasses all critical aspects necessary for Largazole production, including the cost of Largazole production, Largazole plant cost, Largazole production costs, and the overall Largazole production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Largazole production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.
Largazole is an FDA approved drug that finds specific applications in the medical and pharmaceutical industries. It is utilized as a potent drug for the treatment of brain cancer and various other central nervous system diseases due to its HDAC inhibitory activity. Additionally, it also finds its medical applications in chemical biology for research activities and developing new targeted therapies.
The market for Largazole is driven by its usage as an effective class I selective histone deacetylase inhibitor drug used for the treatment of cancer and certain CNS diseases, which significantly promotes its demand in the pharmaceutical industry. Moreover, its application in research to study cell differentiation, apoptosis, etc., and developing new drugs further enhances its demand in the medical, biotechnology, and research & development industries. Furthermore, several factors influence industrial Largazole procurement, such as the availability of raw materials (sodium bicarbonate, etc.), cost and pricing, regulatory compliance, quality standards, technological advancements, environmental considerations, sustainability practices, distribution (including trading and shipping), logistics, safety standards, etc.
Raw Material for Largazole Production
According to the Largazole production plant project report, the major raw materials for Largazole production include α,β-Epoxy aldehyde-Thioester.
Manufacturing Process of Largazole
The extensive Largazole production cost report consists of the following industrial production process:
- Production from α,β-Epoxy Aldehyde: This method of production is initiated by the reaction of α,β-epoxy aldehyde, and thioester that contains a tetrazoyl sulfone moiety to give alkenes, followed by N-heterocyclic carbene–mediated esterification with fluoren-9-ylmethanol to form an azido thioester. Further, the obtained azido thioester is reacted with triphenylphosphine (PPh3) in the presence of acetonitrile under microwave irradiation to form polypeptide followed by Yamaguchi esterification and macrolactamization, leading to the formation of Largazole as the final product.
Largazole is a cyclodepsipeptide, and it exists in the form of a solid powder. Moreover, the molecular formula of the compound is C29H42N4O5S3, and its molar mass is 622.9 g/mol. Its recommended storage temperature is -20 degrees Celsius. Additionally, the density of the compound is 1.3 g/cm3, and the index of refraction is 1.633.